Key Insights

Highlights

Treatment Research

3 treatments under study, led by Frequent Baseline Blood Sampling

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 2 (1)

Trial Status

Unknown2

Clinical Trials (2)

Research Network

Common Treatments

  • Frequent Baseline Blood Sampling1
  • Pump1
  • Gonadorelin1

Active Sponsors

  • Massachusetts General Hospital2
  • National Institutes of Health (NIH)1
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1

Top Investigators

Related Conditions

  • Hypogonadotropic Hypogonadism2
  • Amenorrhea2

Activity Timeline